Myelodysplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials